FDA recall D-0520-2022

Teva Pharmaceuticals USA · Class II · drug

Product

Tretinoin Capsules, 10 mg, 100 count bottle, Rx Only, Teva Pharmaceuticals USA, Inc., North Wales, PA 19454, NDC 0555-0808-02

Reason for recall

Failed Dissolution Specifications; Low Out of specification (OOS) results for dissolution.

Distribution

nationwide in the USA

Key facts

Status
Terminated
Initiation date
2022-01-10
Report date
2022-02-09
Termination date
2022-12-21
Voluntary/Mandated
Voluntary: Firm initiated
Location
Parsippany, NJ, United States

Primary source

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0520-2022